Market Research Blog – Page 1170 – New Product Development

Global Orthokeratology Market Set to Reach USD 659.1 Million by 2034 at a 4.80% of CAGR

The global orthokeratology market is poised for steady growth over the coming decade, with an estimated market value of USD 412.4 million in 2024. By 2034, the market is projected to reach USD 659.1 million, registering a compound annual growth rate (CAGR) of 4.80% over the forecast period.

Orthokeratology, a non-surgical treatment used to temporarily reshape the cornea to improve vision, has gained increasing popularity as a safe and effective alternative to corrective lenses and surgery. The rising prevalence of myopia, especially in children and young adults, is one of the key drivers of market growth, as orthokeratology offers an effective solution for managing this condition.

In addition to its benefits for myopia control, orthokeratology is gaining traction due to growing awareness of eye health, advancements in lens technology, and an increasing number of eye care professionals offering this treatment.

Orthokeratology, a non-surgical procedure that uses specially designed contact lenses to temporarily reshape the cornea and correct refractive errors, is gaining popularity as a safe and effective alternative to laser eye surgery. The increasing prevalence of myopia, particularly among children, and the rising demand for non-invasive vision correction solutions are key factors driving market growth.

Orthokeratology, also known as corneal refractive therapy, involves the use of specially designed contact lenses to reshape the cornea and correct vision. The growing awareness of the benefits of this non-surgical approach to vision correction is driving demand and contributing to market expansion.

Additionally, high prevalence of chronic diseases like diabetic retinopathy is expected to positively influence the market prospects. Developments such as the emergence of ingenious orthokeratology products and of implantable intraocular lenses will bolster the future possibilities for the orthokeratology market.

Though the orthokeratology market looks forward to an overall healthy future market prospects, it is not without its share of restraints. High initial cost of orthokeratology lenses, increasing cases of corneal infection in pediatric patients, less market penetration of the product along with a lack of skilled professional are factors that may subdue the growth of the orthokeratology market over the forecast period.

“High incidences of myopia and better benefits of Ortho-K lens as compared to the conventional ones are likely to boost the sales of orthokeratology in the global market over the forecast period,” says an FMI analyst.

Key Takeaways:

High initial costs of the lenses may hinder market growth.
The US to account for a major share of market revenue by 2028.
The orthokeratology market in China will record a high CAGR over the forecast period.
By indication, the myopia segment will continue to be a major market driver.
On the basis of distribution channels, optometry clinics will register the highest demand.

Competitive Landscape

The Cooper Companies Inc., Euclid Systems Corporation, Menicon Co., Ltd., GP Specialists, Inc., TruForm Optics, Inc., Art Optical Contact Lens, Inc., MiracLens L.L.C., and Contex, Inc, among others, are some of the major players in the orthokeratology market that are profiled in the full version of the report.

Major market players are focused on establishing stronghold in China and Japan. Mergers and collaborations are certain tactics that these businesses employ to retain a competitive advantage.

More Insights into the Orthokeratology Market Report

In its latest report, FMI offers an unbiased analysis of the global orthokeratology market, providing historical data from 2013 to 2021 and forecast statistics for 2022 to 2028. To understand the global market potential, growth, and range, the market is segmented based on indication (myopia, presbyopia, hyperopia, astigmatism), distribution channel (hospitals, optometry clinics, ophthalmology clinics), and region.

According to the latest FMI reports, based on region, the orthokeratology market in the United States is expected to undergo significant growth over the forecast period. The region is predicted to acquire a major chunk of the global market share by 2028. This growth can be attributed to the presence of a well-developed and established healthcare sector. Favorable government initiatives in the healthcare sector also support this market growth.

In China, the orthokeratology market is projected to exhibit a high CAGR over the forecast period. The region is expected to offer multiple lucrative opportunities to the orthokeratology market. Prolonged usage of electronic devices such as laptop, smartphones, tablets, etc., has led to high rates of chronic eye damage. With high prevalence of myopia and hyperopia, the target market in China is expected to grow at a rapid rate.

Based on segmentation, by indication, the myopia segment will likely create substantial market opportunities while, in terms of distribution channels, optometry clinics will dominate the market over the forecast period.

A Old Full Report Analysis Click Here

Key Segments Covered in Orthokeratology Industry Survey

Orthokeratology Market by Indication:

Myopia
Presbyopia
Hyperopia
Astigmatism

Orthokeratology Market by Distribution Channel:

Hospitals
Optometry Clinics
Ophthalmology Clinics

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Meningococcal Vaccine Market to Reach USD 9014 Million by 2034 at a 8.6% of CAGR

The global meningococcal vaccine market is poised for robust growth, with an estimated valuation of USD 3950.2 million in 2024, projected to reach approximately USD 9014 million by 2034. This reflects a significant compound annual growth rate (CAGR) of 8.6% over the forecast period from 2024 to 2034.

The growth of the meningococcal vaccine market is primarily driven by the rising incidence of meningitis cases worldwide. According to recent data, there were approximately 2.51 million global cases of meningitis in 2019, with 1.28 million of these cases occurring in children under the age of five. The severity and potential fatality of the disease have heightened concerns, prompting a growing number of people to seek vaccination.

This trend is especially notable in countries with well-established healthcare infrastructures, such as the United States, the United Kingdom, India, and China, where proactive vaccination programs are gaining momentum. As awareness of the importance of meningitis prevention continues to rise, the demand for meningococcal vaccines is expected to increase significantly over the coming decade.

In a recent report, FMI unveils groundbreaking insights, positioning the conjugate vaccines segment as the industry frontrunner, commanding an impressive 62.6% revenue share in 2021. This highlights the pivotal role of conjugate vaccines in shaping the market landscape and steering its overall success.

The anticipated growth in the Global Meningococcal Vaccines Industry reflects a collective effort towards enhancing global healthcare and preventing the spread of meningococcal diseases. With advancements in vaccine technologies and increasing awareness about the importance of immunization, the industry is set to play a pivotal role in safeguarding public health.

Partnerships between the private sector and public institutions have been the chief agenda of global public health initiatives.

The last few years have witnessed an increase in several private-public partnerships specifically focussing on vaccine provision in developing countries. Partnerships like the International Coordinating Group on Vaccine Provision for Epidemic Meningitis Control (ICG) help magnify the vaccine outreach to remote areas of the world with the maximum need.

The governments of several countries across the globe initiate immunisation programmes periodically and these programmes are backed by global organisations such as UNICEF and WHO and private not-for-profits like the Global Alliance for Vaccines and Immunization (GAVI).

A classic example of how private-public partnerships are helping boost vaccination programmes across deep regional pockets is Brazil.

In 2010, Ezequiel Dias Foundation, Brazil formed a strategic alliance with Novartis Vaccines & Diagnostics for the sustainable supply of Menjugate MenC vaccines for Brazil’s National Immunization Program. By 2015, Brazil became self-sufficient in the production of the meningococcal C conjugated vaccine for the country’s public vaccination programmes. Such initiatives at the global level are anticipated to support global immunisation goals and at the same time boost the growth of the Global Meningococcal Vaccines Industry

Key Companies Profiled in the Global Meningococcal Vaccines Industry:

Sanofi Pasteur Inc.
GlaxoSmithKline Plc
Wyeth Pharmaceuticals
Bio-Manguinhos
Bio-Med Pvt. Limited
Chongqing Zhifei Biological Products Co., Ltd.
Hualan Biological Engineering Inc.
Incepta Pharmaceuticals Ltd.
Pfizer INC
Serum Institute of India Pvt. Ltd
Walvax Biotechnology Co., Ltd.

Factors Leading to Worldwide Adoption of Meningococcal Vaccination Programmes

The Global Meningococcal Vaccines Industry is expected to be driven by enhanced access to vaccines in low and middle-income countries, growing investments by manufacturers and governments to cope with pandemic meningitis outbreaks, and rapidly growing consumption of meningococcal vaccines bolstered by immunisation alliances and mass vaccination campaigns among others.

Partnerships and alliances between manufacturers and governmental healthcare organisations are facilitating the speedy introduction of vaccines in some of the economically challenged countries of the Middle East and Africa region. Enhanced access to vaccines in under-penetrated global markets is expected to accelerate revenue growth of the global meningococcal vaccines market.

Approval of new vaccines in the U.S and Europe in 2015 and 2017 to treat meningococcal meningitis has revolutionised the global immunisation landscape. This is further boosting the growth trajectory of the global market for meningococcal vaccines.

GlaxoSmithKline to Lead the Global Meningococcal Vaccines Industry with About 50% Market Share Recorded in 2017

The Global Meningococcal Vaccines Industry is highly consolidated, with GlaxoSmithKline and Sanofi together holding about 80% of the global market share in 2017. Pfizer is the third largest company in this market with just under 12% market share in 2017.

Companies are expanding their production capacities through the acquisition of established vaccines production units of other global or local companies.

Sanofi has a huge pipeline of 17 active meningococcal vaccines programmes and is targeting emerging markets; while GlaxoSmithKline has 5 active pipeline programmes for meningococcal vaccines, all of which are in the phase II clinical stage. Addition of the vaccine Bexsero has enabled GlaxoSmithKline to defend its brand against Sanofi’s aggressive portfolio in the paediatric vaccines space.

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Groundbreaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Key Market Segments Covered in Meningococcal Vaccines Industry Research

By Product:

Polysaccharide
Conjugate

By Age Group:

Infants
Children
Adolescents and Young Adults
Adults

By Distribution Channel:

Pharmacies
Community Clinics
Public Health Agencies
Others (hospital pharmacy, private market etc.)

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Global Veterinary Molecular Diagnostics Market to Surpass USD 377.22 Million by 2033 at a 6.84% of CAGR

The global veterinary molecular diagnostics market is projected to experience significant growth over the next decade. Valued at USD 194.47 million in 2023, the market is expected to exceed USD 377.22 million by 2033, registering a compound annual growth rate (CAGR) of 6.84% during the forecast period.

This growth is driven by increasing demand for accurate and early disease detection in animals, as well as rising awareness about animal health and preventive veterinary care. Veterinary molecular diagnostics provide advanced solutions for diagnosing infectious diseases, genetic disorders, and other health conditions in animals, ensuring better treatment outcomes.

As the global pet population continues to grow, coupled with advancements in veterinary healthcare technologies, the need for reliable molecular diagnostics is on the rise. Additionally, the growing importance of livestock health, fueled by the expanding animal husbandry industry, is further contributing to the demand for these diagnostics.

This significant growth is driven by increasing demand for advanced diagnostic tools that enhance the accuracy and efficiency of veterinary care. The rising adoption of molecular diagnostics in veterinary practices is improving disease detection, management, and prevention, which is contributing to the market’s expansion.

The market is segmented based on product type, disease type, species type, end-user, and region. On the basis of product type, the market has been segmented into four segments such as PCR kits, INAAT kits, microarray kits, DNA sequencing kits.

PCR kits segment is expected to be the fastest-growing segment over the forecast period, registering a significant CAGR of 7.8% in terms of revenue, over the forecast period. The increasing demand for advanced veterinary molecular diagnostic kits, such as RT-PCR kits, DNA sequencing kits, and microarray-based diagnostic kits owing to the growing number of diagnostic procedures in livestock and companion animals worldwide is expected to boost the growth of the veterinary molecular diagnostics market over the forecast period.

The PCR kits segment dominates the market with a market value of US$ 63.4 Mn in 2017. Also, the segment is expected to maintain its dominance over the forecast period with a market value of US$ 124.0 by 2026 end and expands at a significant CAGR.

On the basis of disease type, the market has been segmented into Anaplasma spp., Ehrlichia spp., New Castle Disease, Influenza, Porcine Reproductive & Respiratory Syndrome (PRRS), and others.

Based on species type, the market has been segmented into livestock animals including Aquatic, Bovine, Porcine, Ovine, Poultry, and Equine.

On the basis of end-user, the market has been segmented into veterinary hospitals, clinical laboratories, and veterinary research institutes.

On the basis of region, the market has been segmented into North America, Latin America, Europe, the Asia Pacific Excluding China (APEC), China, and the Middle East and Africa (MEA).

Increasing set up of new production facilities by the key manufacturers in growing economies coupled with increasing adoption of molecular diagnostic techniques in animals is anticipated to boost the production for molecular diagnostic kits and drives the growth of the veterinary molecular diagnostics market over a forecast period.

The increasing prevalence of chronic disorders in animals such as influenza, new castle disease, and diabetes coupled with the high prevalence of infectious diseases is further anticipated to fuel the demand for the veterinary molecular diagnostics market. Increasing preference for molecular diagnosis on the account of their high specificity and efficacy in diagnosing chronic diseases in animals and the presence of a strong distribution channel is further anticipated to drive the growth of the veterinary molecular diagnostics market over the forecast period. Rising adoption of pets, increasing financial grants for innovation in veterinary diagnostics, fast FDA approvals for reagents used in animal molecular diagnostics, and increased consumer spending on veterinary care is also expected to drive the market revenue growth over the forecast period.

Increasing spending on pet care in developing economies such as Japan and India in the APEC region is anticipated to have a positive impact on the veterinary molecular diagnostics market in the APEC region. However, the increasing demand for advanced veterinary molecular diagnostic kits, such as RT-PCR kits, DNA sequencing kits, and microarray-based diagnostic kits owing to the growing number of diagnostic procedures in livestock and companion animals is further anticipated to drive the growth of the veterinary molecular diagnostics market in North America and Europe over the forecast period.

However, gaps in epidemiological knowledge of certain virulent veterinary diseases, high costs associated with veterinary molecular diagnosis and stringent regulatory approval process for novel molecular diagnostic kits resulting into product delays, may hamper the demand for veterinary molecular diagnostic kits and restrain the growth of veterinary molecular diagnostics market over forecast period. Also, the improper veterinary care research infrastructure in the emerging economies, limited reimbursement policies and Visa restrictions strangling vet practices coupled with shortage of veterinary doctors and colleges are some other factors anticipated to hinder the growth of the global veterinary molecular diagnostics market.

This report assesses trends driving the growth of segmental markets and offers analysis and insights into the regional veterinary molecular diagnostics market. North America is estimated to dominate the veterinary molecular diagnostics market with a maximum value share by the end of 2017. By 2026, North America and Europe markets cumulatively are expected to account for over 67.8% revenue share of the global veterinary molecular diagnostics market by the end of 2026.

Some key companies covered in this report include bioMérieux SA, IDEXX Laboratories, Inc., Thermo Fisher Scientific Inc., Qiagen N.V., Neogen Corporation, ID.Vet, INDICAL BIOSCIENCE GmbH, and Veterinary Molecular Diagnostics, Inc. These leading players focus to consolidate their position in the global veterinary molecular diagnostics market by actively participating in activities such as partnerships, mergers, acquisitions and collaborations. Companies focus on extending their product line and expansion of production capacities to meet the growing demands for veterinary molecular diagnostics kits worldwide.

A Old Full Report Analysis Click Here

The global veterinary molecular diagnostics market is segmented as follows:

By Product Type

PCR kits
INAAT kits
Microarray kits
DNA sequencing kits

By Disease Type

Anaplasma spp.
Ehrlichia spp.
New Castle Disease
Influenza
Porcine Reproductive & Respiratory Syndrome (PRRS)
Others

By Species

Livestock Animals
- Aquatic
- Bovine
- Porcine
- Ovine
- Poultry
- Equine
Companion Animals
- Canine
- Feline
- Avian

By End User

Veterinary Hospitals
Clinical Laboratories
Veterinary Research Institutes

About Future Market Insights (FMI)

Contact Us:

Global Gait Trainer Market Expected to Reach USD 456.3 Million by 2028 at a 4.9% of CAGR

The global gait trainer market is projected to grow at a steady compound annual growth rate (CAGR) of 4.9% over the forecast period, according to the latest industry analysis by Future Market Insights. The market, valued at USD 342.7 million in 2022, is expected to reach an estimated USD 456.3 million by the end of 2028.

In 2021, the broader exoskeleton market, valued at USD 4.1 billion, saw gait trainer sales contributing 8% of this total. The growth of gait trainer sales, particularly those designed for individuals with cerebral palsy, is driven by a significant rise in the incidence of this condition. This trend highlights the increasing need for effective rehabilitation solutions tailored to cerebral palsy patients.

Research Methodology

FMI adopts a triangulation methodology to provide accurate and precise market estimations and insights for various medical devices and technologies. This approach primarily relies on patient-level data, the number of procedures, and the capital equipment installation base obtained through experimental techniques. The bottom-up approach is always used to obtain country-specific data and then analyze it to generate global data. This ensures the data’s high quality and accuracy.

In the initial stage, secondary research is conducted to determine the feasibility of the target products/technology categories, segments, product offerings, usage patterns, device lifespan, reimbursement scenarios, adoption rates, and future impact of new technologies. Each piece of information is meticulously analyzed to create a solid foundation for primary research.

Primary research involves the participation of demand-side users, including key opinion leaders, physicians, and surgeons, and supply-side providers of medical devices. These stakeholders provide valuable insights on trends, key treatment patterns, adoption rates, purchasing patterns, technological advancements, patient education, manufacturer effectiveness, pricing, and competitive dynamics. This information is further analyzed throughout the research project to ensure comprehensive and accurate market insights.

To project Year-on-Year (Y-o-Y) growth rates for the market, we conduct a quantitative and qualitative assessment of the fundamental factors driving demand, economic factors and cycles, and growth rates, as well as the strategies used by key players. These Y-o-Y growth projections are adjusted and aligned according to the industry/product lifecycle and utilized to develop holistic market numbers.

Additionally, we analyze the annual reports, investor presentations, SEC filings, 10k reports, and press releases of various companies operating in this market segment to obtain detailed information on market size, trends, opportunities, drivers, restraints, key players, and their market shares. These key companies are classified into tiers based on their revenue, product portfolio, and market presence.

It’s important to note that these are only the initial steps in developing the market size. In addition to disease-related factors, we use our internal proprietary model for forecasting, which takes into account various macroeconomic factors such as per capita healthcare expenditure, disposable income, industry-based demand driving factors, and their impact on the market forecast trends.

A Old Full Report Analysis Click Here

Gait Trainer Market Taxonomy

The Gait Trainer Market has been segmented on the following basis:

End User

Hospitals
Rehabilitation Center
Homecare Setting

Product Type

Gait Trainer Walker
Adult
Pediatric
Treadmill System
Exoskeleton

About Future Market Insights (FMI)

Contact Us:

Orthopedic Trauma Devices Market to Reach USD 21.24 Billion by 2034 at a 6.4% of CAGR

The global orthopedic trauma devices market is expected to witness significant growth over the next decade, with an estimated market size of USD 11.39 billion in 2024. The market is projected to exceed a valuation of USD 21.24 billion by 2034, registering a moderate compound annual growth rate (CAGR) of 6.4%.

This growth is driven by the rising incidence of trauma-related injuries, road accidents, and sports-related fractures, which are fueling demand for advanced orthopedic trauma devices. Innovations in medical technology and the development of minimally invasive procedures are also contributing to market expansion, providing improved outcomes for patients.

As the global aging population increases, the prevalence of osteoporosis and other bone-related conditions is expected to rise, further propelling the need for orthopedic trauma devices. The market’s growth is set to benefit from increased healthcare spending and advancements in orthopedic treatments that focus on faster recovery times and reduced complications.

In conclusion, the global orthopedic trauma devices market is on track for substantial growth, driven by an aging population, technological advancements, and rising demand for effective trauma care solutions. Industry stakeholders are encouraged to continue innovating and developing products that meet the evolving needs of healthcare providers and patients.

Key Companies Profiled:

Medtronic, Inc.
Invibio Ltd.
OsteoMed
Weigao Group Co Ltd.
Arthrex, Inc.
Johnson & Johnson Company
CONMED, Tornier, Inc.
Stryker Corporation
Zimmer Holding Inc.
NuVasive
Medartis
Olympus Corporation

Based on the regional analysis, the global orthopedic trauma devices market will continue to witness dominance of North America, which currently accounts for a major portion of the total revenues. With around 48% value share observed in 2021, North America’s orthopedic trauma devices market is estimated to attain a value in excess of US$ 6 Bn by the end of 2028. Western Europe is also identified to be a key market, holding the second largest position in terms of value.

Manufacturers will however discover attractive opportunities in developing economies, including Asia Pacific, Latin America, and Middle East and Africa. Among the emerging regional markets, Asia Pacific excluding China and Japan (APECJ) is likely to emerge at a relatively higher pace, followed by MEA. China is expected to be the most lucrative market owing to the highest estimated CAGR value over 2022-2028. Strong presence of key companies will reportedly uplift the markets in North America and China.

Key Segments Covered in Orthopedic Trauma Devices Industry Research

Orthopedic Trauma Devices Market by Product Type:

Internal Fixators
- Screws
- Intramedullary Nails
- Plates
- Others (Wires, Pins, Staples)
External Fixators
- Unilateral Fixators
- Circular Fixators
- Hybrid Fixators

Orthopedic Trauma Devices Market by Product Type by End User:

Hospitals
Orthopedic and Trauma Centers
Ambulatory Surgical Centers

Orthopedic Trauma Devices Market by Region:

North America Orthopedic Trauma Devices Market
Latin America Orthopedic Trauma Devices Market
Europe Orthopedic Trauma Devices Market
East Asia Orthopedic Trauma Devices Market
South Asia & Pacific Orthopedic Trauma Devices Market
Middle East & Africa (MEA) Orthopedic Trauma Devices Market

About Future Market Insights (FMI)

Contact Us:

Global Cellulite Treatment Market Expected to Surpass USD 7.37 Billion by 2034 at a 7.2% of CAGR

The global cellulite treatment market is poised for substantial growth, with an estimated valuation of USD 3.67 billion in 2024. Projections indicate that the market will grow at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2034, reaching an impressive value of over USD 7.37 billion by the end of the forecast period.

The rising prevalence of cellulite, driven by the global obesity epidemic, is a key factor behind this market expansion. Poor dietary habits and increasingly sedentary lifestyles are contributing to higher rates of obesity, which is anticipated to fuel the demand for effective cellulite treatment solutions.

The market growth is further supported by advancements in non-invasive and minimally invasive treatment options, along with increasing consumer awareness of aesthetic wellness. As more individuals seek treatments for cellulite reduction and skin smoothing, industry stakeholders are focusing on innovative technologies to meet this growing demand.

In summary, the global cellulite treatment market is set for remarkable growth over the next decade, driven by rising obesity rates and the demand for advanced aesthetic treatments. Companies in the sector are encouraged to invest in research and development to offer cutting-edge solutions that align with evolving consumer preferences.

This growth is largely attributed to the global obesity epidemic, which is primarily driven by poor eating habits and sedentary lifestyles. The rising prevalence of obesity is anticipated to be a major factor fueling the demand for effective cellulite treatment solutions in the coming decade.

Hard Cellulite is Predicted to Hold an Attractive Market Share shortly

One major driver behind the growth of the cellulite treatment Industry is the increasing number of obese population. There is also an increased number of cases of fat deposition. The people who are comparatively overweight mostly face this problem, in turn triggering the demand for cellulite treatment. These cases have helped people grow aware of cosmetic surgeries and have also broadened the scope of these surgeries in the market. There’s a significant rise in aesthetic procedures taking place worldwide.

Especially in Brazil, where around 5,500 cosmetic surgeons were performing the second highest number of aesthetic procedures after the U.S. Around 1,450,020 minimally invasive and non-surgical procedures were performed in Brazil in 2016. Among different types of cellulite, hard cellulite is expected to register a growth rate of around 7.8% during 2022-2028, which is higher than other cellulite types.

North America Slated for Strongest Projections in the Global Cellulite Treatment Industry

Among the major regional divisions made for the research conducted on the global cellulite treatment Industry, North America shows the strongest prospects with an expected market value of over US$ 2,100 Mn by the end of 2028, growing at an impressive CAGR of 8.1% during the forecast period. The growth is helped by North America’s moderate economy and healthcare market.

Also, in the U.S., a large base of the population, especially youngsters, suffer from fat deposition-related disorders. The region is also ahead of other regions due to its developed economy and advanced facilities. The cellulite treatment involves advanced techniques which are also costly for people to afford. This makes the market more prominent in developed regions like North America.

A Old Full Report Analysis Click Here

Key Segments of Cellulite Treatment Market Survey

by Treatment Procedure:

Non-Invasive Cellulite Treatment
Minimally Invasive Cellulite Treatment
Topical Cellulite Treatment

by Cellulite:

Soft Cellulite
Hard Cellulite
Edematous Cellulite

by End User:

Cellulite Treatment in Hospitals
Cellulite Treatment in Ambulatory Surgical Centres
Cellulite Treatment in Specialized Dermatology Clinics

by Region:

North America Cellulite Treatment Market
Latin America Cellulite Treatment Industry
Europe Cellulite Treatment Market
East Asia Cellulite Treatment Industry
South Asia & Pacific Cellulite Treatment Market
Middle East & Africa (MEA) Cellulite Treatment Industry

Author

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Global Varicella Zoster Infection Treatment Market Projected to Reach USD 2.0 Billion by 2028 at a 4.1% of CAGR

The global varicella zoster infection treatment market is anticipated to experience significant growth, with estimates indicating a market value of over USD 1.5 billion in 2020. Projections suggest the market will reach approximately USD 2.0 billion by 2028, reflecting a compound annual growth rate (CAGR) of 4.1%.

According to Future Market Insights, acyclovir is expected to maintain a substantial share of over 55.7% in the overall varicella zoster infection treatment market in 2022. This antiviral medication is widely recognized for its efficacy in treating infections caused by the varicella zoster virus, including chickenpox and shingles.

The rising prevalence of varicella zoster infections, coupled with an increasing awareness of the importance of timely and effective treatment, is driving demand for medications in this market. Additionally, ongoing research and development efforts to enhance treatment options and improve patient outcomes are expected to contribute to market growth.

Acute varicella may be complicated by secondary bacterial skin infections, cerebellitis, encephalitis, hemorrhagic complications, and viral and bacterial pneumonia. The climate is a core factor that seems to have an impact on the epidemiology of varicella. In most of the temperate climatic regions, 90% of the people are infected before adolescence. In tropical climates, VZV infection occurs later in life and adults are more susceptible to it than children.

On the other hand, herpes zoster or shingles is a sporadic disease that is caused by the reactivation of latent VZV in the sensory nerve ganglia. It is usually self-limiting and is categorized by severe pain with dermatomal distribution and at times followed by post-herpetic neuralgia that can be chronic and debilitating among the geriatric population.

Though herpes zoster can occur at any age, most of the cases are reported after the age of 50 along with increasing risks of complications.

To cater to the needs of the patients and provide a potential treatment for this infection, companies are entering into strategic partnerships to make use of the technology of the other leading companies and are also focussing on research and development.

Risk of Varicella in Pregnancy and the Need to Adhere to the Guidelines of Chickenpox Treatment to Bode Well for the Market

Primary infection with varicella zoster in pregnancy may cause maternal mortality or serious morbidity issues. A particular guideline issued in 2015 assesses the evidence regarding maternal and fetal risks of varicella-zoster virus infection in pregnancy. The U.K. Advisory Group and Swiss and Canadian national guidelines prescribe procedures for the use of antiviral drugs in pregnancy. The U.K. Advisory Group provides guidelines for chickenpox as well.

These guidelines recommend oral acyclovir, which should be prescribed for pregnant women within 24 hours once they present the onset of the rash and if they have 20+0 weeks of gestation or beyond. Guidelines are unanimous nevertheless, in recommending that intravenous acyclovir be administered in cases of severe maternal infection. This factor along with the fact that the rate of exposure and transmission is extremely high in this infection and is a threat for pregnant women and kids, is expected to boost the growth of the varicella zoster infection treatment market.

Natural Products to Challenge Market Growth

Several people opt for other treatment options for herpes zoster and varicella. These alternative treatment options are expected to hamper the growth of the antiviral drugs market for varicella zoster infection treatment. Homeopathy, supplements, and other natural herbal medicines are used to treat herpes zoster and varicella.

Varicella Zoster Infection Treatment Market Key Players:

Novartis AG,
Pfizer Inc.,
Abbott Laboratories,
Sun Pharmaceuticals Industries Ltd.,
Valeant Pharmaceuticals International Inc.,
Teva Pharmaceutical Industries Ltd.,
Dr. Reddy’s Laboratories, ltd.,
Mylan N.V. and
GlaxoSmithKline

Varicella Zoster Infection Treatment Market Segmentation – by Category

By Drug Type:

Acyclovir
Valacyclovir
Famciclovir

By Route of Administration:

Oral
Injectable
Topical

By Distribution Channel:

Hospital pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Near Field Communication Market to Soar, Expected to Reach USD 100.59 Billion by 2034 at a 14.7% CAGR

The global Near Field Communication (NFC) Market is poised for substantial growth, with the market value projected to rise from USD 25,522.81 million in 2024 to an impressive USD 100,591.84 million by 2034. This reflects a strong Compound Annual Growth Rate (CAGR) of 14.7% over the forecast period. NFC technology, which enables short-range wireless communication between devices, is being increasingly adopted across various sectors, from mobile payments and transportation to retail and healthcare, driving this market expansion.

NFC is transforming the way consumers interact with technology, offering fast, secure, and convenient contactless transactions. The technology has seen widespread use in mobile payments, contactless ticketing, and secure access control, with industries leveraging its ability to enhance customer experience and operational efficiency.

Key Takeaways from the Market Study

The Near Field Communication Market is projected to grow from USD 25,522.81 million in 2024 to USD 100,591.84 million by 2034, at a robust CAGR of 14.7%.
Increasing demand for contactless payments, especially in the wake of the COVID-19 pandemic, is driving the adoption of NFC technology across various industries.
Smartphones continue to dominate as the primary NFC-enabled devices, but applications are expanding into wearables, smart cards, and IoT devices.
Asia-Pacific is anticipated to witness the fastest growth due to the rapid adoption of digital payment systems and smart city initiatives, while North America remains a key market driven by technology innovation and a robust digital ecosystem.

Drivers and Opportunities

The key driver propelling the growth of the Near Field Communication Market is the growing demand for contactless payments and mobile wallets. NFC-based payment solutions, such as Apple Pay, Google Pay, and Samsung Pay, have gained immense popularity due to their convenience, security, and speed. The COVID-19 pandemic further accelerated the shift towards contactless payment methods, as consumers and businesses sought to minimize physical contact during transactions.

Additionally, the expansion of smart cities and connected devices is creating new opportunities for NFC technology. Governments and private sector companies are increasingly deploying NFC-enabled devices for public transportation systems, access control, and secure identity verification. With the rise of the Internet of Things (IoT), NFC is finding applications in a range of connected devices, from wearable fitness trackers to smart home appliances, contributing to the market’s future growth.

Furthermore, the adoption of NFC in retail is reshaping customer experiences, enabling faster checkouts, personalized promotions, and improved inventory management. Retailers are leveraging NFC technology to offer seamless payment options, loyalty programs, and real-time interaction with customers through smart product tagging.

Components Insights

The Near Field Communication Market can be segmented into NFC chips, NFC tags, NFC readers, and software solutions. Among these, NFC chips form the largest component segment, as they are integral to enabling contactless communication in smartphones, payment terminals, and wearables.

NFC readers are also experiencing growing demand, particularly in retail, transportation, and access control applications. These readers are used in point-of-sale (POS) systems, public transport systems, and security systems to enable quick and secure interactions with NFC-enabled devices. Software solutions, including mobile wallets and NFC-based access control systems, are expanding rapidly, with a focus on enhancing the user experience and ensuring data security.

Application Insights

Mobile payments represent the largest application segment within the NFC Market, fueled by the increasing use of smartphones for contactless transactions. The rising penetration of mobile wallets and the preference for contactless payments by consumers and businesses alike are expected to continue driving this segment.

In addition to mobile payments, NFC technology is finding growing applications in transportation and ticketing systems. NFC-enabled smart cards and mobile apps allow commuters to pay for rides seamlessly, reducing the need for physical tickets. The deployment of NFC in public transportation systems, particularly in urban areas, is gaining traction as cities invest in smart infrastructure.

Other key application areas include healthcare, where NFC is being used for patient identification, medical record access, and secure medication dispensing. The retail sector is also leveraging NFC for inventory management, customer engagement, and loyalty programs.

Deployment Insights

In terms of deployment, the cloud-based segment is expected to witness significant growth over the forecast period. Cloud-based NFC solutions provide scalability, real-time updates, and enhanced security, making them attractive to businesses and organizations looking to implement NFC for payment processing, access control, and data management. Cloud-based systems enable seamless integration with mobile applications and other digital platforms, driving adoption across industries.

On the other hand, on-premises deployment is still relevant for organizations with strict security and data privacy concerns. Industries like banking, healthcare, and government, which require stringent control over data access and storage, continue to rely on on-premises solutions to ensure compliance with regulatory requirements.

Key Companies & Market Share Insights

The Near Field Communication Market is highly competitive, with key players continuously innovating to expand their product offerings and improve technology capabilities. Leading companies in this space include NXP Semiconductors, Broadcom Corporation, Qualcomm Technologies, Inc., STMicroelectronics, and Sony Corporation.

These companies are investing in R&D to develop advanced NFC chips, readers, and software solutions that offer enhanced performance, security, and reliability. Strategic partnerships, mergers, and acquisitions are common in the industry, as companies seek to strengthen their market position and expand their customer base.

For example, NXP Semiconductors continues to lead the market with its portfolio of NFC chips, offering solutions that power a wide range of applications, from mobile payments to IoT devices. Qualcomm Technologies, Inc. is focusing on integrating NFC into its next-generation smartphone chipsets, further driving the adoption of NFC technology in mobile devices.

Recent Developments

In 2023, Sony Corporation launched its latest series of NFC-enabled wearables, designed for secure access control and mobile payment solutions, targeting both the consumer electronics and enterprise markets.
NXP Semiconductors announced a partnership with Mastercard to expand contactless payment capabilities across Europe, integrating NFC technology into new payment terminals for retail and transportation.
STMicroelectronics introduced a new range of NFC readers designed for smart city applications, enabling contactless ticketing and access control solutions for urban transit systems.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

RegTech Market Set to Soar, Expected to Reach USD 82.99 Billion by 2034, Driven by Increasing Regulatory Demands

The global RegTech Market is experiencing rapid growth, with the market size projected to rise from USD 14,259.8 million in 2024 to an impressive USD 82,997.2 million by 2034. This represents a Compound Annual Growth Rate (CAGR) of 19.2% over the forecast period, reflecting the increasing demand for regulatory technology (RegTech) solutions across various industries.

RegTech, which refers to technology solutions designed to help businesses comply with regulations efficiently and cost-effectively, is becoming an essential part of operations in financial services, healthcare, and other highly regulated sectors. With the proliferation of complex regulatory requirements, financial institutions, fintech companies, and other organizations are adopting RegTech tools to manage risk, ensure compliance, and reduce the administrative burden.

Key Takeaways from the Market Study

The global RegTech Market is projected to grow from USD 14,259.8 million in 2024 to USD 82,997.2 million by 2034, registering a robust CAGR of 19.2%.
Financial services remain the dominant application segment, driven by the need for compliance with stringent regulations such as GDPR, AML, and KYC.
North America is expected to continue leading the global market due to a well-established regulatory landscape, while Asia-Pacific is anticipated to witness the fastest growth, fueled by increasing digitization and regulatory reforms.
The adoption of AI and machine learning in RegTech solutions is driving innovation, allowing for real-time monitoring, enhanced risk assessment, and predictive analytics to address regulatory requirements.

Drivers and Opportunities

The primary driver for the rapid growth of the RegTech Market is the ever-evolving regulatory landscape. With increasing regulatory scrutiny across industries, organizations face significant challenges in managing compliance risks, particularly in financial services. RegTech solutions help these companies reduce operational costs, minimize the risk of non-compliance, and streamline compliance management through automation and advanced data analytics.

The rise of data privacy laws such as the General Data Protection Regulation (GDPR) in Europe and the California Consumer Privacy Act (CCPA) in the U.S. has further boosted demand for RegTech solutions. Organizations are required to ensure the security and privacy of customer data, making compliance with data protection regulations a critical focus.

The proliferation of AI and machine learning technologies in RegTech is creating new opportunities for businesses to manage compliance in real-time, with advanced analytics capable of identifying potential risks and recommending preventive actions. The integration of blockchain technology for secure data sharing and smart contracts also holds significant promise for the RegTech sector.

Components Insights

The RegTech Market is segmented into several key components, including software solutions and services. Software solutions, which include platforms for risk management, regulatory reporting, identity management, and transaction monitoring, make up the largest segment of the market.

These software platforms allow companies to automate processes such as Anti-Money Laundering (AML) compliance, Know Your Customer (KYC) requirements, and risk assessment. By automating routine compliance tasks, organizations can significantly reduce the time and resources required to maintain compliance, while improving accuracy and transparency.

Services offered by RegTech providers, such as consulting, implementation, and managed services, also play a critical role in ensuring the seamless integration of RegTech solutions into existing infrastructures. As companies continue to adopt more advanced technologies, the need for ongoing support and customization is driving demand for RegTech-related services.

Application Insights

The financial services industry, encompassing banks, insurance companies, investment firms, and fintech organizations, represents the largest application area for RegTech solutions. The financial sector is heavily regulated, and organizations within this space are required to comply with a range of regulations covering everything from anti-money laundering to customer identity verification.

In addition to financial services, healthcare, telecommunications, and energy industries are increasingly adopting RegTech solutions to manage complex regulatory environments. The healthcare industry, for instance, relies on RegTech tools to comply with data privacy laws like HIPAA, while the energy sector uses these solutions to adhere to environmental and safety regulations.

Deployment Insights

RegTech solutions are deployed in cloud-based and on-premises models. Cloud-based deployment is expected to dominate the market, driven by its scalability, flexibility, and cost-effectiveness. Cloud-based RegTech solutions allow businesses to integrate new features, access real-time data, and ensure that systems remain up-to-date with evolving regulations without significant upfront investments.

On-premises solutions, while still in demand, are becoming less popular as organizations shift toward cloud solutions for their compliance management needs. However, industries with strict data security concerns, such as finance and healthcare, continue to adopt on-premises models to retain control over sensitive information.

Key Companies & Market Share Insights

The global RegTech Market is highly competitive, with major players continually developing new solutions to keep pace with regulatory changes. Leading companies include Thomson Reuters, Wolters Kluwer, IBM Corporation, FIS Global, ACTICO, and Trulioo. These companies offer a range of RegTech solutions aimed at improving regulatory compliance, enhancing risk management, and optimizing data governance.

Strategic partnerships, mergers, and acquisitions are common in the RegTech space, as companies look to expand their service offerings and enhance their market positions. For instance, IBM Corporation continues to invest heavily in AI-powered RegTech solutions that leverage its Watson platform for real-time risk monitoring and regulatory reporting.

Recent Developments

In 2023, Wolters Kluwer launched an enhanced version of its regulatory reporting solution, which integrates AI-driven analytics to improve accuracy in compliance reporting and streamline the audit process for financial institutions.
Thomson Reuters introduced a new cloud-based risk management platform that enables financial institutions to track global regulatory changes in real time and assess their impact on compliance.
Trulioo, a global identity verification provider, expanded its operations into new markets, offering comprehensive KYC and AML compliance services for businesses in Europe and the Asia-Pacific region.

Request a Sample of this Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-15096

About Future Market Insights (FMI)

Contact Us:

Pharma Robots Market Insights, Deep Analysis of Key Vendor in the Industry 2022 to 2032

The pharma robots market is poised for substantial growth, with a projected annual surge of 13.8% CAGR, catapulting its anticipated worth to an impressive US$ 683.4 million by the year 2032. This surge underscores the increasing integration of robotics in the pharmaceutical industry, where automation plays a pivotal role in enhancing efficiency, precision, and overall productivity. The escalating demand for advanced pharmaceutical manufacturing processes and the need for high-throughput solutions are key factors driving this robust growth.

As the industry continues to embrace technological advancements, the pharma robots market is positioned as a critical player in shaping the future of pharmaceutical production, promising innovative solutions and transformative outcomes for the global healthcare landscape.

To avoid drug overfill and minimize adulteration, Clemson University and Nephron Pharmaceuticals Corporation, for instance, have developed a tabletop robot that can fill, cap, and seal sterile pre-filled syringes. Syringe filling is still a highly controlled operation that requires specialist workers to complete in ISO-certified clean rooms in the absence of robots. To help hospitals and other healthcare facilities deal with a shortage of pre-filled needles, a robot was created.

Key Takeaways from the Pharma Robots Market Report:
The Pharma Robots Market is poised for significant growth, projected to reach a substantial market size of US$ 188.6 Million by 2022. Notably, the Traditional Robots segment is anticipated to exhibit the highest CAGR of 14.5% throughout the forecast period. The United States is positioned as the dominant market, presenting an absolute dollar growth opportunity of US$ 153.4 Million from 2022 to 2032. Meanwhile, Japan is anticipated to experience the highest CAGR of 16.1% during the same forecast period, emphasizing the global expansion and technological advancements within the Pharma Robots Market. These trends underscore the increasing importance and widespread adoption of robotic technologies in the pharmaceutical industry, with both traditional and emerging markets contributing to the sector’s remarkable growth.

Competitive Landscape:
The market is fiercely competitive, where key players are increasingly focused on obtaining a competitive advantage. The key companies in the Pharma Robots Market are focused on R&D to produce innovative technological solutions.

In December 2021, the Marchesini Group-Neri Division’s BL-A309 was displayed at FCE Pharma, a flexible solution for Print&Check and serialization processes that allow users to swiftly install all of the major pharmaceutical traceability devices on the market, from laser printers to ink-jet technologies.

In December 2021, Universal Robots launched a virtual pharma event, where managers, experts, and other professionals in the pharmaceutical and medical technology industries learned about the various possibilities that robots provide. Universal Robots can be promising in the pharmaceutical industry and are already generating a significant buzz in the market.

In May 2021, Fanuc augmented its SCARA robot line to provide more reach and payload alternatives to companies that are looking to automate assembly, packaging, pick-and-place, and inspection processes. New models with payload capacities of 3, 6, and 20 kg are SR-3iA, SR-6iA, SR-12iA, and SR-20iA. The reach of the models ranges from 400 to 1,000 mm.

Leading Key Players:
ABB Ltd., Universal Robots, Kawasaki Heavy Industries Ltd., Yaskawa Electric Corporation, FANUC America Corporation, Marchesini Group S.P.A, Seiko Epson Corporation, Denso Wave Incorporation, Jianjia Robots

Request a Sample Report for Comprehensive Insights
https://www.futuremarketinsights.com/reports/sample/rep-gb-15094

About Future Market Insights (FMI)

Contact Us: